Investor Relations
Partnerships are integral to Harbour BioMed's strategy to build a fully integrated biopharmaceutical company.
| Analyst(s) | Firm |
| Jin Yang, Yizheng Yang, Yanyin Zhu | China International Capital Corporation (CICC) |
| Hanyang Huang, Yuanyuan Sun, Xicheng Yang | Industrial Securities |
| GuoGuang Zhu, Feng Su, Xingjian Zou | Soochow Securities |
| Minxiu He, Mengmeng Han, Yin Ye | Ping An Securities |
| Guangkai Liang, Feifei Xu, Yupeng Jiao | China Merchants Securities |
| Jiaqi Zhu, Yishan Mu | Zhongtai Securities |
| Song Yang, Huiyao Li | Tianfeng Securities |
This list of analysts was prepared based on material that was available at the time of writing. Therefore, please note that there may be other analysts who have not been included in this list, and that some of the information may not be the latest.
Please note that the analysts have conducted their own analyses of the Company's performance, businesses, products and technologies, and have developed their own forecasts. These processes do not in any way involve the Company or the management of the Company.